CLN6 Gene Ceroid lipofuscinosis neuronal type 6 Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for CLN6 Gene Ceroid lipofuscinosis neuronal type 6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 6
Test Details
The CLN6 gene is associated with a specific type of neurodegenerative disorder called ceroid lipofuscinosis neuronal type 6 (CLN6 NCL). This disorder is characterized by the abnormal accumulation of lipopigments (lipofuscin) in cells, leading to progressive neurological symptoms.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CLN6 NCL, NGS genetic testing can be used to identify mutations or variants in the CLN6 gene that may be responsible for the disorder.
By identifying specific genetic changes in the CLN6 gene, NGS genetic testing can help confirm a diagnosis of CLN6 NCL in individuals with symptoms consistent with the disorder. It can also be used for carrier testing in individuals with a family history of CLN6 NCL to determine if they carry a mutation in the gene.
NGS genetic testing for CLN6 NCL can provide valuable information for patients and their families, including prognosis, genetic counseling, and potential treatment options. However, it is important to note that genetic testing results should always be interpreted by a healthcare professional with expertise in genetics.
Test Name | CLN6 Gene Ceroid lipofuscinosis neuronal type 6 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLN6 Gene Ceroid lipofuscinosis neuronal type 6 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 6 |
Test Details |
The CLN6 gene is associated with a specific type of neurodegenerative disorder called ceroid lipofuscinosis neuronal type 6 (CLN6 NCL). This disorder is characterized by the abnormal accumulation of lipopigments (lipofuscin) in cells, leading to progressive neurological symptoms. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CLN6 NCL, NGS genetic testing can be used to identify mutations or variants in the CLN6 gene that may be responsible for the disorder. By identifying specific genetic changes in the CLN6 gene, NGS genetic testing can help confirm a diagnosis of CLN6 NCL in individuals with symptoms consistent with the disorder. It can also be used for carrier testing in individuals with a family history of CLN6 NCL to determine if they carry a mutation in the gene. NGS genetic testing for CLN6 NCL can provide valuable information for patients and their families, including prognosis, genetic counseling, and potential treatment options. However, it is important to note that genetic testing results should always be interpreted by a healthcare professional with expertise in genetics. |